Your browser is no longer supported. Please, upgrade your browser.
ARYA ARYA Sciences Acquisition Corp. daily Stock Chart
ARYA Sciences Acquisition Corp.
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-2.57%
Market Cap- Forward P/E- EPS next Y-1.36 Insider Trans- Shs Float- Perf Month8.29%
Income- PEG- EPS next Q-0.21 Inst Own- Short Float- Perf Quarter50.30%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y47.80%
Book/sh- P/B- EPS next Y-44.70% ROA- Target Price24.89 Perf Year-
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range9.84 - 17.48 Perf YTD45.67%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-13.33% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low53.94% ATR1.21
Employees2 Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)55.60 Volatility7.51% 8.30%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume1.08 Prev Close15.15
ShortableNo LT Debt/Eq- Earnings- Payout- Avg Volume270.60K Price15.15
Recom2.00 SMA202.16% SMA5019.89% SMA20039.43% Volume0 Change0.00%
Jun-05-20Initiated Chardan Capital Markets Buy $28
Jul-02-20 07:00AM  
Jun-29-20 05:34PM  
Jun-17-20 12:40PM  
Jun-11-20 07:10PM  
Aug-02-19 03:20PM  
ARYA Sciences Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the life sciences and medical technology sectors in North America and Europe. The company was founded in 2018 and is based in New York, New York.